Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;66(9):1146-1155.
doi: 10.1111/aas.14124. Epub 2022 Aug 23.

Platelet transfusions and thrombocytopenia in intensive care units: Protocol for an international inception cohort study (PLOT-ICU)

Affiliations

Platelet transfusions and thrombocytopenia in intensive care units: Protocol for an international inception cohort study (PLOT-ICU)

Carl Thomas Anthon et al. Acta Anaesthesiol Scand. 2022 Oct.

Abstract

Introduction: Thrombocytopenia is frequent in intensive care unit (ICU) patients and has been associated with worse outcome. Platelet transfusions are often used in the management of ICU patients with severe thrombocytopenia. However, the reported frequencies of thrombocytopenia and platelet transfusion practices in the ICU vary considerably. Therefore, we aim to provide contemporary epidemiological data on thrombocytopenia and platelet transfusion practices in the ICU.

Methods: We will conduct an international inception cohort, including at least 1000 acutely admitted adult ICU patients. Routinely available data will be collected at baseline (ICU admission), and daily during ICU stay up to a maximum of 90 days. The primary outcome will be the number of patients with thrombocytopenia (a recorded platelet count < 150 × 109 /L) at baseline and/or during ICU stay. Secondary outcomes include mortality, days alive and out of hospital, days alive without life-support, the number of patients with at least one bleeding episode, at least one thromboembolic event and at least one platelet transfusion in the ICU, the number of platelet transfusions and the indications for transfusion. The primary and secondary outcomes will be presented descriptively. In addition, we will assess risk factors for developing thrombocytopenia during ICU stay and the association between thrombocytopenia at baseline and 90-day mortality using logistic regression analyses.

Conclusion: The outlined international PLOT-ICU cohort study will provide contemporary epidemiological data on the burden and clinical significance of thrombocytopenia in adult ICU patients and describe the current platelet transfusion practice.

Keywords: intensive care unit; platelet transfusion; thrombocytopenia.

PubMed Disclaimer

Conflict of interest statement

The Department of Intensive Care 4131 at Rigshospitalet (CTA, MHM, AP, LR) has received funding for other projects from the Novo Nordisk Foundation, Pfizer, Ferring Pharmaceuticals and Fresenius Kabi and conducts contract research for AM‐Pharma. PP had received honoraria for lectures and participation in advisory boards from Merck Sharp & Dohme, Sanofi, Gilead and Pfizer.

Figures

FIGURE 1
FIGURE 1
Study overview. Patients will be included during a 14‐day inception period chosen by the local investigator. During this period, all acutely admitted adult patients will be screened for inclusion at ICU admission. Eligible patients will be followed daily during their intensive care unit stay (and subsequent stays if readmitted to a participating ICU) until day 90 after which the follow‐up will be completed. Baseline variables are registered at inclusion, and daily registrations are performed for each day in the ICU to a maximum of 90 days. Follow‐up variables are registered at the end of day 90. ECMO, extra corporeal membrane oxygenation; ICU, intensive care unit; SMS‐ICU, simplified mortality score in the intensive care unit

Similar articles

Cited by

  • Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU).
    Anthon CT, Pène F, Perner A, Azoulay E, Puxty K, Van De Louw A, Barratt-Due A, Chawla S, Castro P, Póvoa P, Coelho L, Metaxa V, Kochanek M, Liebregts T, Kander T, Hästbacka J, Andreasen JB, Péju E, Nielsen LB, Hvas CL, Dufranc E, Canet E, Lundqvist L, Wright CJ, Schmidt J, Uhel F, Ait-Oufella H, Krag M, Cos Badia E, Díaz-Lagares C, Menat S, Voiriot G, Clausen NE, Lorentzen K, Kvåle R, Hildebrandt T, Holten AR, Strand K, Tzalavras A, Bestle MH, Klepstad P, Fernandez S, Vimpere D, Paulino C, Graça C, Lueck C, Juhl CS, Costa C, Bådstøløkken PM, Miranda T, Lêdo LSA, Sousa Torres JC, Granholm A, Møller MH, Russell L; on behalf of the PLOT-ICU Collaborators and the Nine-I Study Group. Anthon CT, et al. Intensive Care Med. 2023 Nov;49(11):1327-1338. doi: 10.1007/s00134-023-07225-2. Epub 2023 Oct 9. Intensive Care Med. 2023. PMID: 37812225 Free PMC article.
  • Platelet transfusion practice in the intensive care unit: the Nine-I international platelet transfusion survey.
    Russell L, Azoulay E, Anthon CT, Pène F, Akella P, Mabrouki A, Puxty K, Nielsen LB, Andreasen JB, Kander T, Sjövall F, Hästbacka J, Hvas CL, Van De Louw A, Chawla S, Bauer PR, Castro P, Povoa P, Coelho L, Fernandez S, Topeli A, Barratt-Due A, Barbaglio C, Kochanek M, Martin-Loeches I, Kentish-Barnes N. Russell L, et al. Ann Intensive Care. 2025 Jul 8;15(1):91. doi: 10.1186/s13613-025-01494-4. Ann Intensive Care. 2025. PMID: 40627074 Free PMC article.
  • Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub-study of the PLOT-ICU cohort.
    Anthon CT, Pène F, Perner A, Azoulay E, Puxty K, Van De Louw A, Chawla S, Castro P, Povoa P, Coelho L, Metaxa V, Kochanek M, Liebregts T, Kander T, Sivula M, Møller MH, Russell L. Anthon CT, et al. Acta Anaesthesiol Scand. 2024 Mar;68(3):434-440. doi: 10.1111/aas.14365. Epub 2023 Dec 19. Acta Anaesthesiol Scand. 2024. PMID: 38115558 Free PMC article.
  • Platelet transfusions in adult ICU patients with thrombocytopenia: A sub-study of the PLOT-ICU inception cohort study.
    Anthon CT, Pène F, Perner A, Azoulay E, Puxty K, Van De Louw A, Chawla S, Castro P, Povoa P, Coelho L, Metaxa V, Kochanek M, Liebregts T, Kander T, Sivula M, Andreasen JB, Nielsen LB, Hvas CL, Dufranc E, Canet E, Wright CJ, Schmidt J, Uhel F, Missri L, Krag M, Cos Badia E, Díaz-Lagares C, Menat S, Voiriot G, Erikstrup Clausen N, Lorentzen K, Kvåle R, Barratt-Due A, Hildebrandt T, Holten AR, Strand K, Bestle MH, Klepstad P, Vimpere D, Paulino C, Lueck C, Juhl CS, Costa C, Bådstøløkken PM, Lêdo LSA, Møller MH, Russell L. Anthon CT, et al. Acta Anaesthesiol Scand. 2024 Sep;68(8):1018-1030. doi: 10.1111/aas.14467. Epub 2024 Jun 5. Acta Anaesthesiol Scand. 2024. PMID: 38840310 Free PMC article.

References

    1. Williamson DR, Lesur O, Tétrault JP, Nault V, Pilon D. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes. Can J Anesth. 2013;60:641‐651. - PubMed
    1. Crowther MA, Cook DJ, Meade MO, et al. Thrombocytopenia in medical‐surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care. 2005;20:348‐353. - PubMed
    1. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. 2002;30:1765‐1771. - PubMed
    1. Jonsson AB, Rygård SL, Hildebrandt T, Perner A, Møller MH, Russell L. Thrombocytopenia in intensive care unit patients: a scoping review. Acta Anaesthesiol Scand. 2021;65:2‐14. - PubMed
    1. Cawley MJ, Wittbrodt ET, Boyce EG, Skaar DJ. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy. 1999;19:108‐113. - PubMed

LinkOut - more resources